Total Holdings
265
Portfolio diversification across 265 positions
BIB
(NASDAQ)ProShares Ultra Nasdaq Biotechnology
$83.66-- (--)
Loading... - Market loading
BIB ETF Holdings: ProShares Ultra Nasdaq Biotechnology
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$85.65M
Total fund assets
Expense Ratio
0.95%
Annual management fee
Fund Issuer
ProShares
NASDAQ
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 43 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Gilead Sciences, Inc | Stock | 6.48% |
| 2 |  | Vertex Pharmaceuticals Incorporated | Stock | 6.27% |
| 3 |  | Amgen Inc | Stock | 6.15% |
| 4 |  | Regeneron Pharmaceuticals, Inc. | Stock | 4.37% |
| 5 |  | Alnylam Pharmaceuticals, Inc. | Stock | 2.34% |
| 6 |  | Insmed Incorporated | Stock | 1.93% |
| 7 |  | Biogen Inc. | Stock | 1.44% |
| 8 |  | United Therapeutics Corporation | Stock | 1.37% |
| 9 |  | argenx SE | Stock | 1.17% |
| 10 |  | Royalty Pharma plc | Stock | 1.15% |
| 11 |  | Roivant Sciences Ltd. | Stock | 1.12% |
| 12 |  | Revolution Medicines, Inc. | Stock | 1.08% |
| 13 |  | Illumina, Inc. | Stock | 1.08% |
| 14 |  | Moderna, Inc. | Stock | 1.07% |
| 15 |  | Incyte Corporation | Stock | 1.05% |
| 16 |  | Viatris Inc | Stock | 0.87% |
| 17 |  | Summit Therapeutics Inc. | Stock | 0.83% |
| 18 |  | BridgeBio Pharma, Inc. | Stock | 0.78% |
| 19 |  | Medpace Holdings, Inc. | Stock | 0.78% |
| 20 |  | Ascendis Pharma AS | Stock | 0.72% |
| 21 |  | Neurocrine Biosciences, Inc | Stock | 0.66% |
| 22 |  | Ionis Pharmaceuticals, Inc | Stock | 0.66% |
| 23 |  | Sanofi | Stock | 0.65% |
| 24 |  | Guardant Health, Inc | Stock | 0.61% |
| 25 |  | BioMarin Pharmaceutical Inc | Stock | 0.60% |
| 26 |  | Exelixis, Inc | Stock | 0.59% |
| 27 |  | Jazz Pharmaceuticals plc | Stock | 0.58% |
| 28 |  | BioNTech SE | Stock | 0.56% |
| 29 | B BGNE | BeiGene, Ltd | Stock | 0.50% |
| 30 |  | Madrigal Pharmaceuticals, Inc | Stock | 0.49% |
| 31 | N NK | NantKwest Inc | Stock | 0.48% |
| 32 |  | Tempus AI, Inc. Class A Common Stock | Stock | 0.46% |
| 33 |  | Arrowhead Pharmaceuticals, Inc | Stock | 0.43% |
| 34 |  | Praxis Precision Medicines, Inc | Stock | 0.42% |
| 35 |  | Axsome Therapeutics, Inc | Stock | 0.42% |
| 36 |  | Halozyme Therapeutics, Inc | Stock | 0.41% |
| 37 |  | Vaxcyte, Inc | Stock | 0.41% |
| 38 |  | Krystal Biotech, Inc | Stock | 0.40% |
| 39 |  | Cytokinetics, Incorporated | Stock | 0.38% |
| 40 |  | Nuvalent Inc | Stock | 0.37% |
| 41 | P PINK:AAVXF | ABIVAX Société Anonyme | Stock | 0.36% |
| 42 |  | Arcellx Inc | Stock | 0.33% |
| 43 |  | Kymera Therapeutics, Inc | Stock | 0.33% |
Frequently Asked Questions About ProShares Ultra Nasdaq Biotechnology Holdings
What are the top holdings in BIB?
ProShares Ultra Nasdaq Biotechnology (BIB) holds 265 securities. View the complete list of top holdings sorted by portfolio weight, showing each security's ticker symbol, company name, asset type, and allocation percentage.
How concentrated is BIB's portfolio?
Portfolio concentration is measured by the weight of top holdings. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly. Review BIB's holdings table to analyze concentration risk.
What is BIB's sector allocation?
The Sector Allocation chart shows how BIB distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does BIB invest in?
BIB's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is BIB ETF?
BIB's diversification can be assessed by reviewing its 265 holdings, sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.